“Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC”. Radiology and Oncology 59, no. 4 (December 16, 2025): 617–623. Accessed September 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/4451.